First in Human, Single Ascending Dose Study
Clinical trial NCT05844592 · COMPLETED
Trial details
- NCT number
- NCT05844592
- Sponsor
- Innovo Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-21
- Primary completion
- 2022-07-16
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.